These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28253202)

  • 1. Evaluation of the shielding in a treatment room with an electronic brachytherapy unit.
    Ibanez-Rosello B; Bautista-Ballesteros JA; Candela-Juan C; Villaescusa JI; Ballester F; Vijande J; Perez-Calatayud J
    J Radiol Prot; 2017 Jun; 37(2):N5-N12. PubMed ID: 28253202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison and uncertainty evaluation of different calibration protocols and ionization chambers for low-energy surface brachytherapy dosimetry.
    Candela-Juan C; Vijande J; García-Martínez T; Niatsetski Y; Nauta G; Schuurman J; Ouhib Z; Ballester F; Perez-Calatayud J
    Med Phys; 2015 Aug; 42(8):4954-64. PubMed ID: 26233221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation protection measurements around a 12 MeV mobile dedicated IORT accelerator.
    Soriani A; Felici G; Fantini M; Paolucci M; Borla O; Evangelisti G; Benassi M; Strigari L
    Med Phys; 2010 Mar; 37(3):995-1003. PubMed ID: 20384235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shielding implications for secondary neutrons and photons produced within the patient during IMPT.
    DeMarco J; Kupelian P; Santhanam A; Low D
    Med Phys; 2013 Jul; 40(7):071701. PubMed ID: 23822405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and use of a 2D-array of ion chambers for brachytherapy dosimetric quality assurance.
    Yewondwossen M
    Med Dosim; 2012; 37(3):250-6. PubMed ID: 22189031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal dose measurements and shielding efficiency assessment in a custom setup of (192)Ir brachytherapy for a pregnant woman with breast cancer.
    Candela-Juan C; Gimeno-Olmos J; Pujades MC; Rivard MJ; Carmona V; Lliso F; Celada F; Ramírez-Coves JL; Ballester F; Tormo A; Perez-Calatayud J
    Phys Med; 2015 May; 31(3):286-92. PubMed ID: 25681030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model-based approach of scatter dose contributions and efficiency of apron shielding for radiation protection in CT.
    Weber N; Monnin P; Elandoy C; Ding S
    Phys Med; 2015 Dec; 31(8):889-896. PubMed ID: 26112350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shielding requirements in helical tomotherapy.
    Baechler S; Bochud FO; Verellen D; Moeckli R
    Phys Med Biol; 2007 Aug; 52(16):5057-67. PubMed ID: 17671353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation evaluation of NIST air-kerma rate calibration standard for electronic brachytherapy.
    Hiatt JR; Rivard MJ; Hughes HG
    Med Phys; 2016 Mar; 43(3):1119-29. PubMed ID: 26936699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the need for massive additional shielding of a catheterization laboratory for the implementation of high dose rate 192Ir intravascular brachytherapy.
    Bohan M; Yue N; Nath R
    Cardiovasc Radiat Med; 2000; 2(1):39-41. PubMed ID: 11229061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
    Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-153 as a brachytherapy isotope.
    Enger SA; Fisher DR; Flynn RT
    Phys Med Biol; 2013 Feb; 58(4):957-64. PubMed ID: 23339848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and Mitigation of Secondary Dose Delivered to Electronic Systems in Proton Therapy.
    Wroe AJ
    Technol Cancer Res Treat; 2016 Feb; 15(1):3-11. PubMed ID: 25616623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-installation empirical testing of room shielding for high dose rate remote afterloaders.
    Klein EE; Grigsby PW; Williamson JF; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):927-31. PubMed ID: 8244825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four methods used in determination of secondary shielding requirements for a teletherapy facility: a case study of 137Cs room in Tanzania.
    Muhogora WE; Nyanda AM; Ngoye WM
    Appl Radiat Isot; 2004 Dec; 61(6):1295-302. PubMed ID: 15388124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal intravascular brachytherapy: safety and radiation protection, reliability and precision guaranteed by guidelines, recommendations and regulatory requirements].
    Quast U; Kaulich TW; Lorenz J
    Herz; 2002 Feb; 27(1):7-16. PubMed ID: 11951797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F protection issues: human and gamma-camera considerations.
    Cao Z; Corley JH; Allison J
    J Nucl Med Technol; 2003 Dec; 31(4):210-5. PubMed ID: 14657287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a flattening filter free linear accelerator on structural shielding design.
    Jank J; Kragl G; Georg D
    Z Med Phys; 2014 Mar; 24(1):38-48. PubMed ID: 23763984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and characterization of a new high-dose-rate brachytherapy Valencia applicator for larger skin lesions.
    Candela-Juan C; Niatsetski Y; van der Laarse R; Granero D; Ballester F; Perez-Calatayud J; Vijande J
    Med Phys; 2016 Apr; 43(4):1639. PubMed ID: 27036563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric perturbations of a lead shield for surface and interstitial high-dose-rate brachytherapy.
    Candela-Juan C; Granero D; Vijande J; Ballester F; Perez-Calatayud J; Rivard MJ
    J Radiol Prot; 2014 Jun; 34(2):297-311. PubMed ID: 24705066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.